Spin-off Philae Pharmaceuticals receives investment from Pharma Connect Capital
Wednesday 2 October 2019
- Life Cooperative
The Groningen-based investment fund Pharma Connect Capital today announced it has made an investment in Philae Pharmaceuticals, a dermatology spin-off company from the University Medical Center Groningen (UMCG). This investment will enable Philae Pharmaceuticals to start the development of targeted therapies for severe and difficult-to-treat dermatological diseases.
Working on a treatment for Butterfly Children
The initial disease Philae will focus on is Epidermolysis Bullosa (EB), a very rare but lethal disease for which currently no treatment or cure exists. Patients with EB are known as Butterfly Children because their skin is as vulnerable as the wings of a butterfly. Even the slightest contact or friction can easily tear or blister their skin.
About Philae Pharmaceuticals
Philae Pharmaceuticals (www.philae-pharma.com) is an initiative of late professor Marcel Jonkman, former chairman of the Dermatology Department of UMCG, emeritus chemistry professor Dick Kellogg and pharmacologist Dr. Reinier Schwietert.
About Pharma Connect Capital
Pharma Connect Capital (www.pharmaconnectcapital.com ) is an investment fund that finances early stage drug development. The fund is an initiative of Investerings Fonds Groningen, University Medical Center Groningen and the Noordelijke Ontwikkelings Maatschappij (NOM) and was launched in October 2017.
Focus areas
Life CooperativeLatest news
-
Wednesday 3 April 2024
Founder Talks Life Sciences looks back on a successful eve..
-
Tuesday 20 February 2024
700,000 euros subsidy from PharmaNL for the development of..
-
Thursday 8 February 2024
Succesful matchmaking during Meet & Greet Life Science..
-
Tuesday 23 January 2024
Apply now for your SME Feasibility Voucher
-
Wednesday 17 January 2024
Sabiad secures investment from Pharma Connect Capital for ..
-
Tuesday 19 December 2023
Groundbreaking Results Cement North Netherlands' Role..
-
Wednesday 22 November 2023
UMCG, RUG and regional industries secure substantial grant..
-
Wednesday 27 September 2023
Necessity of medicine production in the Netherlands undisp..
-
Monday 25 September 2023
The consortium led by ParaMedir awarded around €600,00.00 ..
-
Thursday 14 September 2023
Discover your life long career in the Life Sciences!